Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance
Y Yao, Y Zhou, L Liu, Y Xu, Q Chen, Y Wang… - Frontiers in molecular …, 2020 - frontiersin.org
Nanotechnology has been extensively studied and exploited for cancer treatment as
nanoparticles can play a significant role as a drug delivery system. Compared to …
nanoparticles can play a significant role as a drug delivery system. Compared to …
Non-ionic surfactants for stabilization of polymeric nanoparticles for biomedical uses
H Cortés, H Hernández-Parra, SA Bernal-Chávez… - Materials, 2021 - mdpi.com
Surfactants are essential in the manufacture of polymeric nanoparticles by emulsion
formation methods and to preserve the stability of carriers in liquid media. The deposition of …
formation methods and to preserve the stability of carriers in liquid media. The deposition of …
Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …
numerous structurally and functionally different chemotherapeutic agents. MDR is …
A review of stimuli-responsive nanocarriers for drug and gene delivery
Nanotechnology has shown tremendous promise in target-specific delivery of drugs and
genes in the body. Although passive and active targeted-drug delivery has addressed a …
genes in the body. Although passive and active targeted-drug delivery has addressed a …
[HTML][HTML] Theranostic polymeric nanoparticles as a new approach in cancer therapy and diagnosis: a review
The theranostic term is a revolutionary topic in cancer treatment, combining therapeutic and
diagnostic. Theranostic provides an opportunity for diagnosis and response assessment …
diagnostic. Theranostic provides an opportunity for diagnosis and response assessment …
[HTML][HTML] Paclitaxel nano-delivery systems: a comprehensive review
P Ma, RJ Mumper - Journal of nanomedicine & nanotechnology, 2013 - ncbi.nlm.nih.gov
Paclitaxel is one of the most effective chemotherapeutic drugs ever developed and is active
against a broad range of cancers, such as lung, ovarian, and breast cancers. Due to its low …
against a broad range of cancers, such as lung, ovarian, and breast cancers. Due to its low …
Nanodrug delivery in reversing multidrug resistance in cancer cells
S Kapse-Mistry, T Govender, R Srivastava… - Frontiers in …, 2014 - frontiersin.org
Different mechanisms in cancer cells become resistant to one or more chemotherapeutics is
known as multidrug resistance (MDR) which hinders chemotherapy efficacy. Potential …
known as multidrug resistance (MDR) which hinders chemotherapy efficacy. Potential …
Role of integrated cancer nanomedicine in overcoming drug resistance
Cancer remains a major killer of mankind. Failure of conventional chemotherapy has
resulted in recurrence and development of virulent multi drug resistant (MDR) phenotypes …
resulted in recurrence and development of virulent multi drug resistant (MDR) phenotypes …
Nanopreparations to overcome multidrug resistance in cancer
Multidrug resistance is the most widely exploited phenomenon by which cancer eludes
chemotherapy. Broad variety of factors, ranging from the cellular ones, such as over …
chemotherapy. Broad variety of factors, ranging from the cellular ones, such as over …
Recent advances in ovarian cancer: therapeutic strategies, potential biomarkers, and technological improvements
Aggressive and recurrent gynecological cancers are associated with worse prognosis and a
lack of effective therapeutic response. Ovarian cancer (OC) patients are often diagnosed in …
lack of effective therapeutic response. Ovarian cancer (OC) patients are often diagnosed in …